Price target
72.940.000.00%
The 4 analysts offering 1 year price forecasts for PK5 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings to PK5 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PK5 EPS for the last quarter is 1.67 EUR despite the estimation of 1.21 EUR. In the next quarter EPS is expected to reach 3.45 EUR. Track more of BASILEA PHARM.NA SF 1 financials and stay on top of what is up with the company.
In the next quarter BASILEA PHARM.NA SF 1 revenue is expected to reach 137.10 M EUR. Check out BASILEA PHARM.NA SF 1 revenue and earnings and make informed decisions.
According to analysts, PK5 price target is 72.94 EUR with a max estimate of 106.29 EUR and a min estimate of 55.27 EUR. Check if this forecast comes true in a year, meanwhile watch BASILEA PHARM.NA SF 1 stock price chart and keep track of the current situation with PK5 news and stock market news.